Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-24-127275
Filing Date
2024-12-10
Accepted
2024-12-10 17:21:26
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm2430478d1_s1.htm S-1 397981
2 EXHIBIT 1.4 tm2430478d1_ex1-4.htm EX-1.4 43377
3 EXHIBIT 4.5 tm2430478d1_ex4-5.htm EX-4.5 86391
4 EXHIBIT 4.6 tm2430478d1_ex4-6.htm EX-4.6 86491
5 EXHIBIT 5.1(A) tm2430478d1_ex5-1a.htm EX-5.1A 13793
6 EXHIBIT 5.1(B) tm2430478d1_ex5-1b.htm EX-5.1B 14264
7 EXHIBIT 10.36 tm2430478d1_ex10-36.htm EX-10.36 191544
8 EXHIBIT 23.1 tm2430478d1_ex23-1.htm EX-23.1 2950
9 EX-FILING FEES tm2430478d1_ex-filingfees.htm EX-FILING FEES 16132
10 GRAPHIC tm2430478d1_s1img001.jpg GRAPHIC 3063
11 GRAPHIC tm2430478d1_s1img002.jpg GRAPHIC 29320
12 GRAPHIC tm2430478d1_ex5-1bimg001.jpg GRAPHIC 3047
  Complete submission text file 0001104659-24-127275.txt   903567
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-283722 | Film No.: 241539443
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)